Prostate Clinical Trial
Official title:
The Effect of Virtual Reality Glasses Application on Pain, Anxiety, and Patient Satisfaction During a Transrectal Prostate Biopsy: A Randomized Controlled Trial
| NCT number | NCT05509114 |
| Other study ID # | Rumeysa |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | December 25, 2021 |
| Est. completion date | July 27, 2022 |
| Verified date | August 2022 |
| Source | Ataturk University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The study was conducted in a randomized controlled manner to determine the effect of applying virtual reality glasses during transrectal prostate biopsy on pain, anxiety and patient satisfaction.The study was completed with a total of 70 patients, 35 in the intervention group and 35 in the control group, for whom it was decided to perform sample transrectal prostate biopsy for the first time.
| Status | Completed |
| Enrollment | 70 |
| Est. completion date | July 27, 2022 |
| Est. primary completion date | June 20, 2022 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Male |
| Age group | 18 Years to 65 Years |
| Eligibility | Inclusion Criteria: - Those between the ages of 18-65, - Those who volunteer and accept to participate in the research, - Transrectal prostate biopsy procedure performed for the first time, - No communication problem, - Cognitive level scales are suitable for application, - Patients without vision or hearing problems were included in the study. Exclusion Criteria: - Leaving work voluntarily, - Patients whose cognitive level scales were not suitable for application were excluded from the study. |
| Country | Name | City | State |
|---|---|---|---|
| Turkey | Rumeysa Lale TORAMAN | Palandöken | Erzurum |
| Lead Sponsor | Collaborator |
|---|---|
| Ataturk University |
Turkey,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | State-Trait Anxiety Inventory (STAI-I, STAI-II) | It is a test developed by Spielberger et al. that measures state and trait anxiety levels. Its validity and reliability in Turkey was done by O¨ner and Le Compte. The scale consists of two parts, the 'state anxiety scale', which is created with the aim of determining the instantaneous feelings, and the 20-item 'trait anxiety scale', which was created to determine the feelings in general. It is a four degree scale ranging from 'Nothing' to 'All'. Scores range from 20 (low anxiety) to 80 (high anxiety). | up to 24 hours | |
| Primary | The Scale of Patient Perception of Hospital Experience with Nursing Care (PPHEN) | The patient's perception of nursing care scale was developed by Dozier et al. in the USA, and its Turkish validity and reliability were determined by Çoban and Kasikçi.Likert-type scale has 15 statements about the quality of nursing care. A minimum of 15 and a maximum of 75 points can be obtained from the scale. The cut-off point of the scale is 45. Scores above the cut-off point indicate a positive attitude. The increase in the total score obtained from the scale indicates that the patient is satisfied with the nursing care. | up to 24 hours | |
| Primary | Visual Analog Scale for Pain (VAS) | VAS is a scale developed by Price et al34 (1983) and measures the severity of pain in the patient. VAS is a 10 cm long vertical or horizontal scale with two different names (0=no pain, 10=most severe pain). An increase in the score obtained from the scale in the evaluation indicates an increase in pain. | up to 24 hours |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03197896 -
Educational Intervention in Increasing Knowledge About Prostate Cancer in High-Risk Neighborhoods
|
N/A | |
| Completed |
NCT00026689 -
Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
|
||
| Completed |
NCT00547625 -
Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems
|
Phase 2 | |
| Completed |
NCT00648323 -
Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement
|
Phase 4 | |
| Completed |
NCT00579423 -
Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer
|
Phase 2 | |
| Completed |
NCT00342433 -
Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study
|
||
| Active, not recruiting |
NCT03047135 -
Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis
|
Phase 2 | |
| Enrolling by invitation |
NCT06364865 -
AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study
|
||
| Terminated |
NCT03197948 -
Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing Treatment
|
||
| Completed |
NCT00586898 -
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
|
Phase 2 | |
| Recruiting |
NCT04518072 -
Synthetic Metabolic and Genetic Networks for Medical Diagnosics
|
||
| Completed |
NCT01118260 -
Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection
|
Phase 4 | |
| Recruiting |
NCT00923221 -
Collection of Blood From Patients With Prostate Cancer
|
||
| Active, not recruiting |
NCT01078662 -
Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats
|
Phase 2 | |
| Completed |
NCT00423254 -
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
|
Phase 1 | |
| Terminated |
NCT02918227 -
Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia
|
N/A | |
| Completed |
NCT02756975 -
Prostate Core Needle Biopsy
|
N/A | |
| Active, not recruiting |
NCT00572468 -
Statin Therapy Versus Placebo Prior to Prostatectomy
|
N/A | |
| Completed |
NCT00364455 -
Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.
|
Phase 3 | |
| Terminated |
NCT03318367 -
Virtual Reality Education Module in Reducing Anxiety and Increasing Knowledge in Patients With Prostate Cancer Undergoing Radiation Therapy
|
N/A |